DNA sequence information is pivotal to transcription, replication and recombination. DNA structure is dependent upon intracellular conditions such as ion concentration and the presence of proteins that may bind to DNA to facilitate the interconversion between different forms and to stabilize specific secondary structures. Dependent upon the primary DNA sequence, purine-and pyrimidine-rich strands of DNA can adopt fourstranded structures known as G-quadruplexes and i-motifs, respectively. These structures have been proposed to exist in biologically important regions of DNA, e.g. at the end of chromosomes and in the regulatory regions of oncogenes such as c-mvc.
Introduction
DNA has long been considered a favoured target for cancer chemotherapeutic agents. Indeed many of the most effective clinical agents, such as alkylating and intercalating agents, are DNA interactive. Achieving the desired sequence specificity with DNA-interactive agents is considered to be one of the most formidable hurdles in the development of new agents to achieve therapeutic intervention. Often it is not clear why one agent, such as doxorubicin or , is better than the many other analogues tested. In more recent times, the realization that the real targets for these agents are protein-DNA complexes, such as topoisomerase I-DNA or topoisomerase I I-DNA, rather than duplex DNA, has helped in understanding structure-activity relationships and in designing new agents [l-31. Duplex DNA has become a favoured target for selective therapeutics, with the insight into recognition codes to target unambiguously either the minor or major groove of DNA. Thus, Dervan and co-workers have pioneered efforts to target the minor groove using a side-by-side motif originally based upon the 2 : 1 stoichiometry of binding of distamycin to DNA [4] . Chemotherapeutic agents based upon this model and using an unambiguous code for the four possible base pairs (AT, T A , CG, or G C ) have been developed that have some selectivity and in eitro activity [S] . Giovannangeli and Helkne have developed agents that target the major groove using a triple-strand recognition code, which allows stretches of purines to be targeted by oligomers [6] . Zinc-finger-binding peptides can be assembled to read major groove recognition determinants [7] . Thus, three approaches have gained acceptance for targeting DNA to gain sequence selectivity and, sometimes, therapeutic intervention : (i) the minor groove 2 : 1 polyamide approach, (ii) the major groove approach with a triple strand or zinc fingers, and (iii) targeting protein-DNA complexes where the sequence selectivity achieved is not based upon the duplex DNA binding site but the targeting of a special niche created within the vicinity of the protein-DNA interaction site [1, 2] .
G-quadruplex structures and biological significance
In this paper we propose the idea that a fourth class of DNA sequence-selective interactive compounds can be envisaged, in which alternative secondary structures such as G-quadruplexes may represent selective molecular recognition targets [1, 8, 9] . Superhelical torsional stress may be an important determinant of these structures in cells [lo] .
G-quadruplexes have been proposed as targets for drug design [11] [12] [13] [14] [15] . T h e tetrameric arrangement of guanosine has been known since 1962 [16] (Figure 1) . When poly(G) homopolymers were first synthesized in the mid-l960s, they were shown to form very strong self-complemen-tary structures, which were shown, by C D and IR spectroscopies [17, 18] , to be similar to the guanosine tetrads. Fibre diffraction analysis revealed that they were four-stranded nucleic acid structures [19-211. Of the deoxynucleotides, poly(dG) was the most difficult to synthesize and was ultimately also shown to be a four-stranded structure [22] . These structures remained a curiosity for more than 25 years until, beginning in the late 1980s, a series of papers connected these structures to outcomes of biological significance (Figure 2 ). Guanine tetrads were first implicated to be involved in telomeric ends [23, 24] , and also with recombination in immunoglobulin heavy chains, a process that is needed to bring constant regions next to variable regions during differentiation of P-lymphocytes [25] . They were then proposed to be involved in promoter regions of oncogenes [26] , shown to be required in the HIV genome for dimerization [27] , and were implicated in the regulation of the insulin gene [28] . In 1989, in a Perspective article in the Journal of Medicinal Chemistry, I suggested that they might be suitable targets for drug design [l] .
G-quadruplexes exhibit extensive polymorphism and this can arise from both DNA or RNA, where two or more tetrads stack upon each other. Polymorphism arises from strand stoichiometry, strand polarity, and glycosidic torsion angle variation. G-quadruplexes can arise from association of one, two, or four strands (three strands is possible but has yet to be demonstrated). Strand concentration is an important factor in determining which structure is formed. T h e relative arrangement of adjacent backbones can also give rise to the polymorphism. They can all be parallel, three parallel and one antiparallel, adjacent parallel, or alternating parallel. Many T h e connecting loops can also give rise to structural diversity. T h e loops may connect guanine tracts either edgewise or diagonally, and they may be on opposite ends (diagonal or edgewise) or on the same side (edgewise). T h e loops may be either parallel or antiparallel. T h e capping bases or base pairs are generally not very flexible. T h e bases directly adjacent to the tetrads often stack in planar structures, and complementary base pairs can form from the same or different strands.
G-quadruplex G-tetrad
G-quadruplexes are characterized by coordination of cations, usually K+ and occasionally Na+. T h e hole between G-tetrads is well suited to co-ordinating the right size of cations because the two planes of tetrads are lined by eight carboxyl oxygen-6 atoms from guanine. K+ is best suited to fill this cavity and, under physiological conditions (1 50 mM), occupies this position.
In cells, G-quadruplexes seem uniquely suited to be biological signalling molecules, and the occurrence of G-quadruplex binding proteins and proteins that facilitate their formation, or unwinding, adds further weight to their role as mediators of important biological processes [8] .
G-quadruplexes as molecular targets
There are two key properties of G-quadruplexes that make them attractive as molecular switches : (i) the transition from duplex to G-quadruplex that can occur under physiological conditions and (ii) the extensive polymorphism that is determined by the primary sequence of the guanine-rich strand, which can give rise to their structural diversity. However, for them to be useful in biological systems, where switches need to be quickly turned on and off, the equilibrium between the duplex and G-quadruplex forms needs to be under precise control, such that new conditions can quickly result in either folding or unfolding of the G-quadruplexes. DNA folding would presumably require chaperone molecules, while for unfolding, helicases specific for G-quadruplexes are required. [44, 45] . T h e occurrence of these G-quadruplex chaperone and helicasespecific proteins provides additional support for the premise that G-quadruplexes are biologically important signalling molecules. ATP-dependent chromatin remodelling, which gives rise to superhelical torsional stress, is probably necessary for the formation of these structures in duplex DNA [lo] .
A facile interconversion between duplex or single-stranded DNA and G-quadruplex DNA is crucial if G-quadruplex structures are to be associated with switch mechanisms in control of gene expression and telomerase activation. Therefore, an important problem is the discovery and development of agents that affect this equilibrium or change the molecular recognition properties of the G-quadruplex structure [8] . T o intervene in the control of gene expression, we propose three different ways that small drug molecules could affect processes in which G-quadruplexes are involved: (i) drug molecules ('drivers') could mimic chaperone proteins in accelerating the formation of G-quadruplex ; (ii) they could bind to the G-quadruplex and change their molecular recognition properties and so disrupt signalling mechanisms; or (iii) they could inhibit helicase unwinding enzymes. We have identified small molecules that catalyse the folding of the G-rich strand, bind selectively to the resulting Gquadruplex, and inhibit their unfolding by helicases. By one or more of these mechanisms, these compounds affect c-myc gene expression, disrupt telomere maintenance mechanisms, and may block progression through the cell cycle (mediated by topoisomerase I). However, unequivocal evidence for their existence inside cells is still lacking, and this urgently needs to be addressed.
Design of small molecules that interfere with duplex to G-quadruplex transitions
As a starting point in the design of small molecules that interfere with processes that involve G-quadruplexes, we considered the structure of a prototypical G-quadruplex and where recognition specificity might be achieved. In principle, inside intercalation between tetrads, outside-or endstacking, groove binding, or a combination of two or more of these modes could give rise to binding specificity. We also considered ionic interactions between cationic ligand species and the anionic backbone of the G-quadruplex, along with the appropriate spacing for two or more ionic interactions. First-generation compounds were identified through modelling as intercalating 2,6-anthraquinones with a cationic charge separation sufficient to span phosphates on both sides of the G-quadruplex [46] . Second-generation compounds, in the form of pyrelenes, capitalized on increased stacking interactions [47] . Most recently, cationic porphyrins have been synthesized that hold considerable promise for therapeutic application [48] . These compounds have a porphine core that approximates the size of a G-tetrad with the associated hole and meso-substituents that can be varied in size to fit the grooves of a G-quadruplex (see Figure 3 for the evolution of G-quadruplex-interactive agents). Although we have been intimately involved with the development of all three classes of compounds, we have chosen to concentrate on the cationic porphyrins as potential therapeutic agents for a variety of reasons, including their drug-like characteristics (i.e. concentration in the cell nucleus selectively taken up in cancer cells), in vivo activity, lack of toxicity, and the opportunity to synthesize diverse structures. 
